Publicacións en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Salud Mental (26)

2024

  1. An Injectable Composite Co-Assembled Dehydropeptide-Based Magnetic/Plasmonic Lipogel for Multimodal Cancer Therapy

    Advanced Functional Materials, Vol. 34, Núm. 38

  2. Characterization and modulation of voltage-gated potassium channels in human lymphocytes in schizophrenia

    Schizophrenia Research, Vol. 270, pp. 260-272

  3. Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain

    Neural Regeneration Research, Vol. 19, Núm. 8, pp. 1617-1677

  4. Increasing prevalence of self-harm, suicidal behavior and suicidal ideation throughout a three-year period in the context of COVID-19 pandemic in Spain

    Psychiatry Research, Vol. 339

  5. Longitudinal changes in the functional connectivity of individuals at risk of Alzheimer’s disease

    GeroScience, Vol. 46, Núm. 3, pp. 2989-3003

  6. Minimum spanning tree analysis of unimpaired individuals at risk of Alzheimer's disease

    Brain Communications, Vol. 6, Núm. 5

2023

  1. Anxiety and depression played a central role in the COVID-19 mental distress: A network analysis

    Journal of Affective Disorders, Vol. 338, pp. 384-392

  2. Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions

    Psychiatry Research, Vol. 330

  3. Human Breast Milk microRNAs, Potential Players in the Regulation of Nervous System

    Nutrients, Vol. 15, Núm. 14

  4. Proteomic analysis of exosomes derived from human mature milk and colostrum of mothers with term, late preterm, or very preterm delivery

    Analytical Methods, Vol. 15, Núm. 37, pp. 4905-4917

  5. The Effect of Clozapine and Novel Glutamate Modulator JNJ-46356479 on Nitrosative Stress in a Postnatal Murine Ketamine Model of Schizophrenia

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

2022

  1. Antipsychotic-Associated Weight Gain and Clinical Improvement under Clozapine Treatment

    Journal of Clinical Psychopharmacology, Vol. 42, Núm. 1, pp. 75-80

  2. Efficacy of the Therapeutic Game “Trisquel” in the Treatment of Patients With Substance-Related Disorders Randomized Clinical Study

    Frontiers in Psychiatry, Vol. 13

  3. Evaluating maintenance electroconvulsive therapy in Bipolar Disorders: 3-year mirror-image study

    Journal of Affective Disorders, Vol. 298, pp. 58-64

2021

  1. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis

    Early Intervention in Psychiatry, Vol. 15, Núm. 6, pp. 1584-1594

  2. Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients with a First Episode of Psychosis

    Journal of Clinical Psychiatry, Vol. 82, Núm. 6

  3. Proteomic and metabolic profiling of chronic patients with schizophrenia induced by a physical activity program: Pilot study

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 125-138

  4. Thyrotoxic Psychosis Associated with Amiodarone

    Journal of Clinical Psychopharmacology

2020

  1. A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine

    Frontiers in Psychiatry, Vol. 11

  2. Mania as Debut of Cushing's Syndrome

    Case Reports in Psychiatry, Vol. 2020